抗艾滋病毒药物递送的新方法——有哪些新进展？
Novel Approaches for the Delivery of Anti-HIV Drugs-What Is New?
作者信息
das Neves José
机构信息
i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
INEB-Instituto de Engenharia Biomédica, Universidade do Porto, 4200-135 Porto, Portugal.
出版信息
Pharmaceutics. 2019 Oct 28;11(11):554. doi: 10.3390/pharmaceutics11110554.
Abstract
HIV/AIDS continues to be one of the most challenging individual and public health concerns of our days [...].
摘要
艾滋病毒/艾滋病仍然是当今最具挑战性的个人和公共卫生问题之一[...]。
相似文献
1
Novel Approaches for the Delivery of Anti-HIV Drugs-What Is New?抗艾滋病毒药物递送的新方法——有哪些新进展？
Pharmaceutics. 2019 Oct 28;11(11):554. doi: 10.3390/pharmaceutics11110554.
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发：现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.药物向中枢神经系统的递送方法 - 作为完全消除 HIV 主要储存部位以辅助艾滋病治疗的潜在尝试，将抗逆转录病毒药物靶向鼻腔至大脑。
Expert Opin Drug Deliv. 2019 Mar;16(3):287-300. doi: 10.1080/17425247.2019.1583206.
5
STD services for women at truck stop in Tanzania: evaluation of acceptable approaches.坦桑尼亚卡车停靠点针对女性的性传播感染服务：可接受方法的评估
East Afr Med J. 1997 Jun;74(6):343-7.
6
Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS.纳米结构给药系统：增强抗逆转录病毒药物的递送以更好地管理艾滋病毒/艾滋病
Crit Rev Ther Drug Carrier Syst. 2015;32(6):503-33. doi: 10.1615/critrevtherdrugcarriersyst.2015012403.
7
Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview.当前开发抗 HIV 抑制剂的计算方法：概述。
Curr Pharm Des. 2019;25(31):3390-3405. doi: 10.2174/1381612825666190911160244.
8
Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS.白藜芦醇在基于纳米结构的递药系统和 HIV/AIDS 管理方面的最新进展。
J Control Release. 2014 Nov 28;194:178-88. doi: 10.1016/j.jconrel.2014.09.002. Epub 2014 Sep 11.
9
A public health approach to "prevention with positives": the New York State HIV/AIDS Service Delivery System.一种针对“以积极方式预防”的公共卫生方法：纽约州艾滋病毒/艾滋病服务提供系统。
J Public Health Manag Pract. 2005 Jan-Feb;11(1):7-17. doi: 10.1097/00124784-200501000-00003.
10
Advances in brain targeting and drug delivery of anti-HIV therapeutic agents.抗 HIV 治疗药物的脑靶向和药物传递的进展。
Expert Opin Drug Deliv. 2013 Jul;10(7):973-85. doi: 10.1517/17425247.2013.781999. Epub 2013 Mar 20.
引用本文的文献
1
Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances.用于抗HIV治疗的脂质纳米载体：聚焦物理化学性质与生物技术进展
Pharmaceutics. 2021 Aug 19;13(8):1294. doi: 10.3390/pharmaceutics13081294.
本文引用的文献
1
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.全球、区域和国家艾滋病毒发病率、流行率和死亡率，1980-2017 年，并预测至 2030 年，为 195 个国家和地区：全球疾病、伤害和危险因素研究 2017 年的系统分析。
Lancet HIV. 2019 Dec;6(12):e831-e859. doi: 10.1016/S2352-3018(19)30196-1. Epub 2019 Aug 19.
2
Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP).用于替诺福韦艾拉酚胺（TAF）持续释放的储库型植入物用于HIV暴露前预防（PrEP）的特性研究。
Pharmaceutics. 2019 Jul 4;11(7):315. doi: 10.3390/pharmaceutics11070315.
3
Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells.根除人类免疫缺陷病毒1型（HIV-1）感染细胞。
Pharmaceutics. 2019 Jun 1;11(6):255. doi: 10.3390/pharmaceutics11060255.
4
Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery.用于药物稳定性和控释的逆转录酶抑制剂纳米系统
Pharmaceutics. 2019 Apr 27;11(5):197. doi: 10.3390/pharmaceutics11050197.
5
Design of Poly(lactic--glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.用于阴道共同递送格里菲斯素和地匹韦林的聚乳酸-乙醇酸共聚物（PLGA）纳米颗粒的设计及其对HIV预防的协同作用
Pharmaceutics. 2019 Apr 16;11(4):184. doi: 10.3390/pharmaceutics11040184.
6
Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications.将先进的电纺纤维结构与活性剂的时间释放相关联，以满足下一代阴道内给药应用的需求。
Pharmaceutics. 2019 Apr 3;11(4):160. doi: 10.3390/pharmaceutics11040160.
7
Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV.替诺福韦艾拉酚胺透皮给药系统的研发，替诺福韦艾拉酚胺是替诺福韦的前药，对HIV和HBV具有强效抗病毒活性。
Pharmaceutics. 2019 Apr 9;11(4):173. doi: 10.3390/pharmaceutics11040173.
8
Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems.用于阴道和直肠给药的抗HIV微杀菌纳米系统的药物载体
Pharmaceutics. 2019 Mar 26;11(3):145. doi: 10.3390/pharmaceutics11030145.
9
Tenofovir Hot-Melt Granulation using Gelucire to Develop Sustained-Release Vaginal Systems for Weekly Protection against Sexual Transmission of HIV.使用Gelucire进行替诺福韦热熔制粒以开发每周一次预防HIV性传播的缓释阴道给药系统。
Pharmaceutics. 2019 Mar 20;11(3):137. doi: 10.3390/pharmaceutics11030137.
10
Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection.基因治疗方法在HIV感染中实现功能性治愈和保护造血潜能
Pharmaceutics. 2019 Mar 11;11(3):114. doi: 10.3390/pharmaceutics11030114.
Zotero 插件